Innovationseffekte von Patentrechtsreform und neuer Festbetragsregel
In: List Forum Band 31
Markets for pharmaceuticals belong to the most intensly regulated markets. Manufacturers of pharmaceutical products frequently argue that regulatory interventions impede innovative activities. In this paper we scrutinize two important changes of the regulatory framework of the market for pharmaceutical products in Germany and their impacts on the innovative bahaviour of domestic firms. First of all, we examine recent changes in German patent law dealing with patentability of biotechnological products by which European and German legislators intend to take account of scientific and technical progresses in this field and to remove legal uncertainties. Building on this we analyse the German Health System Modernisation Act (Gesundheitssystemmodernisierungsgesetz, GMG) which was enacted in order to enhance the efficiency of Germany's statutory health insurance system. We conclude that the reforms in question are in some ways complementary but mutually neutralizing in others in terms of their impacts on innovative behaviour.(Original text only available in german language)
To our knowledge, this item is not available for
download. To find whether it is available, there are three
1. Check below under "Related research" whether another version of this item is available online.
2. Check on the provider's web page whether it is in fact available.
3. Perform a search for a similarly titled item that would be available.
|This chapter was published in: ||This item is provided by List Gesellschaft e.V. in its series List Forum Chapter with number
31-19.||Handle:|| RePEc:lst:lfchap:31-19||Contact details of provider:|| Postal: Westfälische Wilhelms-Universität, Am Stadtgraben 9, D - 48143 Münster|
Phone: + 49 (0) 2 51 - 83 2 29 04
Fax: + 49 (0) 2 51 - 83 2 83 95
Web page: http://www.list-gesellschaft.de
More information through EDIRC
|Order Information:|| Email: |
When requesting a correction, please mention this item's handle: RePEc:lst:lfchap:31-19. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Lukas Wnuk Lipinski)
If references are entirely missing, you can add them using this form.